相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease
Min-Young Noh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease
Hirosha Geekiyanage et al.
NEUROBIOLOGY OF AGING (2013)
Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases
Li Liu et al.
NEUROBIOLOGY OF AGING (2013)
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?
Michelle M. Mielke et al.
CLINICAL LIPIDOLOGY (2012)
Asiatic acid protects primary neurons against C2-ceramide-induced apoptosis
Xiangnan Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Human fetal tau protein isoform: Possibilities for Alzheimer's disease treatment
Natasa Jovanov-Milosevic et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Soluble Aβ Promotes Wild-Type Tau Pathology In Vivo
Meredith A. Chabrier et al.
JOURNAL OF NEUROSCIENCE (2012)
Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α
Brian M. Barth et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid-β Precursor Protein
Callum Parr et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Serum ceramides increase the risk of Alzheimer disease The Women's Health and Aging Study II
Michelle M. Mielke et al.
NEUROLOGY (2012)
Roles of AMP-activated Protein Kinase in Alzheimer's Disease
Zhiyou Cai et al.
NEUROMOLECULAR MEDICINE (2012)
Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease
M. Kosicek et al.
NEUROSCIENCE LETTERS (2012)
Chain length-specific properties of ceramides
Sabine Groesch et al.
PROGRESS IN LIPID RESEARCH (2012)
Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease-Related Tau Phosphorylation Via PAR-1
Kanae Iijima-Ando et al.
PLOS GENETICS (2012)
The role of APP proteolytic processing in lipid metabolism
Marcus O. W. Grimm et al.
EXPERIMENTAL BRAIN RESEARCH (2012)
Prophylactic lithium alleviates postoperative cognition impairment by phosphorylating hippocampal glycogen synthase kinase-3β (Ser9) in aged rats
LongDe Zhao et al.
EXPERIMENTAL GERONTOLOGY (2011)
The γ-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease
Annamaria Lanzillotta et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease
Tomohiro Onishi et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate
Nobumasa Takasugi et al.
JOURNAL OF NEUROSCIENCE (2011)
Inhibition of Glycogen Synthase Kinase-3β by Angelica sinensis Extract Decreases β-Amyloid-Induced Neurotoxicity and Tau Phosphorylation in Cultured Cortical Neurons
Zhaoxu Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease
Gunnar K. Gouras et al.
ACTA NEUROPATHOLOGICA (2010)
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis
Norman J. Haughey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes Neurodegeneration
Alejandra D. Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease
Arundhati Jana et al.
JOURNAL OF NEUROSCIENCE (2010)
Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease
Maria Jose Metcalfe et al.
MOUNT SINAI JOURNAL OF MEDICINE (2010)
Deregulation of sphingolipid metabolism in Alzheimer's disease
Xingxuan He et al.
NEUROBIOLOGY OF AGING (2010)
Alterations of the Sphingolipid Pathway in Alzheimer's Disease: New Biomarkers and Treatment Targets?
Michelle M. Mielke et al.
NEUROMOLECULAR MEDICINE (2010)
The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases
Oshrit Ben-David et al.
NEUROMOLECULAR MEDICINE (2010)
Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments
Stephanie J. Adams et al.
PLOS ONE (2010)
Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk
R. Takechi et al.
PROGRESS IN LIPID RESEARCH (2010)
Inhibition of glycogen synthase kinase-3β downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A
Ludovic Martin et al.
BRAIN RESEARCH (2009)
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
Archana Mukhopadhyay et al.
FASEB JOURNAL (2009)
Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters
Maho Utsumi et al.
GLYCOCONJUGATE JOURNAL (2009)
Ceramide and neurodegeneration: Susceptibility of neurons and oligodendrocytes to cell damage and death
Arundhati Jana et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
Does Alzheimer's disease begin in the brainstem?
G. Simic et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
Mathew Blurton-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice
Dick Terwel et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice
Ann C. Mckee et al.
BRAIN RESEARCH (2008)
Tau isoform expression and regulation in human cortical neurons
Atul Deshpande et al.
FASEB JOURNAL (2008)
Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin
Inmaculada Cuchillo-Ibanez et al.
FASEB JOURNAL (2008)
ER stress is involved in Aβ-induced GSK-3β activation and tau phosphorylation
Rosa Resende et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Biochemical characterization of phospholipids, sulfatide and heparin as potent stimulators for autophosphorylation of GSK-3β and the GSK-3β-mediated phosphorylation of myelin basic protein in vitro
Fumitaka Kawakami et al.
JOURNAL OF BIOCHEMISTRY (2008)
Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons
Sachin Patil et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-β peptide
Anne Gomez-Brouchet et al.
MOLECULAR PHARMACOLOGY (2007)
Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
Antonella Caccamo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Pavel Katsel et al.
NEUROCHEMICAL RESEARCH (2007)
Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation
Edward Rockenstein et al.
JOURNAL OF NEUROSCIENCE (2007)
Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
K. Leroy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide
Kathleen I. Seyb et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Chronic lithium administration to FTDP-17 tau and GSK-3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert
Tobias Engel et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons
Sachin Patil et al.
NEUROSCIENCE LETTERS (2006)
Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway
Catherine Malaplate-Armand et al.
NEUROBIOLOGY OF DISEASE (2006)
Tau phosphorylation and aggregation in Alzheimer's disease pathology
J Avila
FEBS LETTERS (2006)
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β
T Li et al.
BIOCHEMISTRY (2006)
The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
F Fumagalli et al.
PHARMACOGENOMICS JOURNAL (2006)
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies
H Nakashima et al.
ACTA NEUROPATHOLOGICA (2005)
Intraneuronal β-amyloid expression downregulates the Akt survival pathway and blunts the stress response
J Magrané et al.
JOURNAL OF NEUROSCIENCE (2005)
Inhibition of glycosphingolipid biosynthesis reduces secretion of the β-amyloid precursor protein and amyloid β-peptide
IY Tamboli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
W Noble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neurotoxic calcium transfer from endoplasmic reticulum to mitochondria is regulated by cyclin-dependent kinase 5-dependent phosphorylation of tau
F Darios et al.
JOURNAL OF NEUROSCIENCE (2005)
Dietary fatty acids intake: possible role in cognitive decline and dementia
V Solfrizzi et al.
EXPERIMENTAL GERONTOLOGY (2005)
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
R Brandt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules
GB Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dimeric amyloid β protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease
T Kawarabayashi et al.
JOURNAL OF NEUROSCIENCE (2004)
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase -: Implications for Alzheimer's disease
A Jana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
β-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons
LQ Tong et al.
JOURNAL OF NEUROSCIENCE (2004)
PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations
L Baki et al.
EMBO JOURNAL (2004)
Tau phosphorylation in neuronal cell function and dysfunction
GVW Johnson et al.
JOURNAL OF CELL SCIENCE (2004)
Lithium, a common drug for bipolar disorder treatment, regulates amyloid-β precursor protein processing
Y Su et al.
BIOCHEMISTRY (2004)
Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis (Withdrawn Publication. See vol. 298, 2022) (Withdrawn Publication. See vol. 298, 2022)
L Puglielli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cdk5 is a key factor in tau aggregation and tangle formation in vivo
W Noble et al.
NEURON (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
Isoforms changes of tau protein during development in various species
H Takuma et al.
DEVELOPMENTAL BRAIN RESEARCH (2003)
Glycogen synthase kinase-3β-mediated tau phosphorylation in cultured cell lines
CWC Lee et al.
NEUROREPORT (2003)
Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory
SJ Liu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Visualization of translated tau protein in the axons of neuronal P19 cells and characterization of tau RNP granules
S Aronov et al.
JOURNAL OF CELL SCIENCE (2002)
Increased Aβ peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease
AE Roher et al.
BIOCHEMISTRY (2002)
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Ceramide-induced cell death in primary neuronal cultures: Upregulation of ceramide levels during neuronal apoptosis
RE Toman et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The protein kinase Cdk5 -: Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology
RB Maccioni et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
